Vontobel Holding’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,662
Closed -$899K 1148
2022
Q3
$899K Buy
3,662
+347
+10% +$93.7K 0.01% 564
2022
Q2
$850K Buy
3,315
+1,127
+52% +$304K 0.01% 580
2022
Q1
$719K Sell
2,188
-39
-2% -$12K 0.01% 699
2021
Q4
$807K Buy
2,227
+1,115
+100% +$377K 0.01% 687
2021
Q3
$362K Sell
1,112
-38
-3% -$12.9K ﹤0.01% 894
2021
Q2
$360K Buy
1,150
+62
+6% +$19K ﹤0.01% 861
2021
Q1
$347K Sell
1,088
-151
-12% -$48.3K ﹤0.01% 755
2020
Q4
$404K Buy
+1,239
New +$343K ﹤0.01% 717

Other funds holding ABMD

Vontobel Holding's ABMD Position: Q4 2022 in Review

Vontobel Holding sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,662 shares — an estimated $899K sold.

Vontobel Holding first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $899K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Vontobel Holding reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Vontobel Holding sold 3,662 Abiomed Inc shares in Q4 2022, an estimated $899K.
  • Vontobel Holding first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Vontobel Holding's Abiomed Inc position peaked at $899K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Vontobel Holding's 13F filing for Q4 2022, filed 14 Feb 2023.